Oral PDE4 inhibitors in the management of stable COPD
Almost 1.45 million Australians have some form of chronic obstructive pulmonary disease (COPD). This equates to one in seven Australians over 40 suffering from...
Former CMO Brendan Murphy on leading through a pandemic
Dealing with challenging situations and weighing up the best available evidence is a familiar scenario for medical professionals. But for Professor Brendan Murphy, who led the health response to the COVID-19 pandemic, the scope of the challenge – and the evidence — changed constantly.
Breaking the vicious cycle of chronic pain
This National Pain Week (25 July– 1 August) Australian Pharmacist explores how to help patients cope with chronic pain.
Top tips for a difficult hay fever season
Changing weather patterns could spell trouble ahead for hay fever sufferers. Now is the time to ensure patients have optimum relief.
Supporting patients with endometriosis
Pharmacists can be important allies for the hundreds of thousands of ‘endo warriors’ across the country.
Transition announcements for ACOP and MMR at CPC24
Department announces transition plan, PSA launches credential offer and Credentialed Pharmacist of the Year awarded.
